A preview of the PDF is not available
Systolic and Diastolic BP Control in Metabolic Syndrome Patients with Metadichol® a Novel Nano Emulsion Lipid
Abstract and Figures
Metadichol®,  a nano formulation a mixture of long chain alcohols that is present in many foods like rice and sugar cane and is derived from the waste of the sugar cane industry. It is a renewable resource. Most of the clinical data in literature is a: non-nano formulation either a tablet or capsule which have not shown any efficacy. Given its safety profile, we carried out a small open-label pilot study on diabetic patients with hypertension who had in additional co-morbidities such as dyslipidemia, obesity, and hypertension. None of them were on any hypertensive medication. Our studies on patients for 60 weeks in an open-label study @20mg per day showed that it is possible to bring about improvements in Systolic and diastolic pressure in addition to CRP, VLDL, HDL, Triglycerides and waist circumference reduction and reduction in insulin resistance. Interestingly Vitamin C levels doubled. The study showed a vast improvement over existing therapies and with no side effects minor or major to report.
Figures - uploaded by Palayakotai R Raghavan
All figure content in this area was uploaded by Palayakotai R Raghavan
Content may be subject to copyright.